Table 2.
Theme | Year | Subject | Model | Sample | Results | Ref |
---|---|---|---|---|---|---|
Surgical treatment | 2020 | AI-assisted surgery | CNN | 300 videos in operation | Accuracy = 81.0%; 83.2% (phase; action) | (118) |
2019 | Robot-assisted surgery | da Vinci | Analyze from 206 RACRS patients | RM = 99.3%; 89.6% LN = 16 ± 6; 16 ± 8 LRR = 3.8%; 9.5% (colon; rectal) | (119) | |
2021 | AI-assisted LCRS | da Vinci | Analyze 600 images in 32 videos | DC = 0.84 | (120) | |
2022 | Evaluate short outcomes | Senhance | Review outcomes in 55 Senhance assisted LCRC patients | Ileocecal resection = 32.7% high anterior resection = 20% D3 dissection = 74.5% | (121) | |
2020 | Automatic recognition | CNN | Recognize 71 Lap-S videos | Accuracy = 91.9% | (122) | |
2021 | Liver segment resection | da Vinci Xi | Present a video in a 54-year-old male patient | Operative time = 205 min estimated blood loss = 310 mL | (123) | |
2020 | Operation analysis | AIRAM | Test 25 ICG curve patterns | Processing time = 48.03 s | (24) | |
Chemoradiotherapy | 2019 | Assess therapy effect | RF | Assess performance from 55 patients | AUC = 0.86 | (117) |
2022 | Predict PCR after nCRT | RAPIDS | Study 933 patients | AUC = 0.812; sensitivity = 0.888 specificity = 0.740; NPV = 0.929 PPV = 0.512 | (124) | |
2021 | Assess therapy effect | FFN/LR/SVM | Study 226 LARC patients | Accuracy = 0.67–0.75% AUC = 0.76–0.83% positive = 67–74%; NPV = 70–78% sensitivity = 68–79% specificity = 66–75% | (125) | |
2018 | Predict nCRT effect | DNN | Study 95 patients | Accuracy = 80% | (126) | |
2020 | Predict PCR after nCRT | ANN | Analyze 270 LARC patients | VSR = 1.57 (CEA levels) | (127) | |
2022 | Predict nCRT effect | MSCNN | Assess 150 WSI | AUC = 0.9337; 0.9091 (Camelyon; MSKCC) | (128) | |
2019 | Predict CRT response | CNN | Study 51 RC patients | AUC = 0.83 | (129) | |
2019 | Predict nCRT effect | LR | Study 136 RC patients | AUC = 0.751; 0.831; 0.873 sensitivity = 66%; 71%; 75% specificity = 87.22%; 86.11%; 91.67% (pre-nCRT; early; combined) | (130) | |
2020 | Predict PCR,TRG, and NAR | LR | Collect and classify 132 nCRT and TME patients | AUC = 0.66; 0.80; 0.80 (NAR; PCR; TAG) | (131) | |
2021 | Predict and treat nCRT response | CFs-SVM | Analysis 428 patients | AUC = 0.834; 0.854 (training; validation) | (132) | |
Targeted therapy | 2022 | Identify therapy targets | MCODE | Extract four gene expression profile from database | Identify 8,931 DEGs in CRC patients | (133) |
2022 | Design CAD approach | RF/SVP/CNN | Scanning 1,443 approved drugs | CAD design approach target p53 for treatment | (134) | |
2022 | Monitoring gene expression and drug effect | MLP | Study CRC cells genes phenomics | Mean accuracy = 9.48%↑(single track VS MLP) | (135) | |
2021 | Medicine precision | ML | Study STNs of CRC | The model with novel event freesurvival has a greater prediction | (136) | |
2019 | Tumor target segmentation | CAC-SPP | Evaluate two segmentation of tumor targets | DSC = 0.78 ± 0.08; 0.85 ± 0.03 | (137) |
AIRAM, artificial intelligence based real-time analysis microperfusion; AUC, area under the carve; ANN, artificial neural network; CNN, convolutional neutral network; CAD, computer aided drug; CAC, cascaded atrous convolution; DC, dice coefficient; DNN, deep neural network; DEGs, differential expressed genes; DSC, dice similarity coefficient; FFN, feedforward neural network; ICG, indocyanine green; LN, lymph nodes; LRR, locoregional recurrence rate; LCRS, laparoscopic colorectal surgery; Lap-s, laparoscopic sigmoidoscopy; LR, logistic regression; LARC, local advanced rectal cancer; MSCNN, multi-scale convolutional neural network; MCODE, molecular complex detection algorithm; MLP, machine learning phenomics; ML, machine learning; nCRT, neoadjuvant chemoradiotherapy; NPV, negative predictive value; NAR, neoadjuvant rectal score; PCR, pathological complete response; PPV, positive predictive value; RACRS, robot-assisted colorectal surgery; RM, radical margins; RF, random forest; RAPIDS, radiopathomics integrated prediction system; SVM, support vector machine; STNs, signal transduction network; SPP, spatial pyramid pooling; TRG, tumor regression grade; TME, total mesorectal excision; VSR, variable sensitivity ratio.